167 related articles for article (PubMed ID: 29656070)
1. [Is universal first trimester screening for high risk of preterm preeclampsia clinically meaningful?].
Sentilhes L; Azria E; Schmitz T
Gynecol Obstet Fertil Senol; 2018 Sep; 46(9):617-618. PubMed ID: 29656070
[No Abstract] [Full Text] [Related]
2. ASPRE trial: performance of screening for preterm pre-eclampsia.
Rolnik DL; Wright D; Poon LCY; Syngelaki A; O'Gorman N; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Papaioannou G; Tenenbaum-Gavish K; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Oct; 50(4):492-495. PubMed ID: 28741785
[TBL] [Abstract][Full Text] [Related]
3. Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE).
O'Gorman N; Wright D; Rolnik DL; Nicolaides KH; Poon LC
BMJ Open; 2016 Jun; 6(6):e011801. PubMed ID: 27354081
[TBL] [Abstract][Full Text] [Related]
4. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume.
Sonek J; Krantz D; Carmichael J; Downing C; Jessup K; Haidar Z; Ho S; Hallahan T; Kliman HJ; McKenna D
Am J Obstet Gynecol; 2018 Jan; 218(1):126.e1-126.e13. PubMed ID: 29097177
[TBL] [Abstract][Full Text] [Related]
5. [Predictive and prognostic factors of preeclampsia: Interest of PlGF and sFLT-1].
Vieillefosse S; Guibourdenche J; Atallah A; Haddad B; Fournier T; Tsatsaris V; Lecarpentier E
J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):999-1008. PubMed ID: 27212611
[TBL] [Abstract][Full Text] [Related]
6. Re: Serum PlGF compared to PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment.
Leeson C; Odendaal J; Quenby S
BJOG; 2023 Jun; 130(7):838. PubMed ID: 35446469
[No Abstract] [Full Text] [Related]
7. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.
Audibert F; Boucoiran I; An N; Aleksandrov N; Delvin E; Bujold E; Rey E
Am J Obstet Gynecol; 2010 Oct; 203(4):383.e1-8. PubMed ID: 20691410
[TBL] [Abstract][Full Text] [Related]
8. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
[TBL] [Abstract][Full Text] [Related]
9. Importance of Timing First-Trimester Placental Growth Factor and Use of Serial First-Trimester Placental Growth Factor Measurements in Screening for Preeclampsia.
Mosimann B; Amylidi-Mohr S; Höland K; Surbek D; Risch L; Raio L
Fetal Diagn Ther; 2017; 42(2):111-116. PubMed ID: 28199996
[TBL] [Abstract][Full Text] [Related]
10. Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year.
Lourenço I; Gomes H; Ribeiro J; Caeiro F; Rocha P; Francisco C
Rev Bras Ginecol Obstet; 2020 Jul; 42(7):390-396. PubMed ID: 32559792
[TBL] [Abstract][Full Text] [Related]
11. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
[TBL] [Abstract][Full Text] [Related]
12. Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study.
Karampas GA; Eleftheriades MI; Panoulis KC; Rizou MD; Haliassos AD; Metallinou DK; Mastorakos GP; Rizos DA
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():153-7. PubMed ID: 27599094
[TBL] [Abstract][Full Text] [Related]
13. Developing a new algorithm for first and second trimester preeclampsia screening in twin pregnancies.
Maymon R; Trahtenherts A; Svirsky R; Melcer Y; Madar-Shapiro L; Klog E; Meiri H; Cuckle H
Hypertens Pregnancy; 2017 Feb; 36(1):108-115. PubMed ID: 27835040
[TBL] [Abstract][Full Text] [Related]
14. [Preeclampsia: Should screening and pronostic biomarkers be used in common clinical practice?].
Hamdi SM; Sault C; Piver E; Genoux A; Masson D; Guibourdenche J
Presse Med; 2019 Oct; 48(10):1032-1036. PubMed ID: 31676218
[No Abstract] [Full Text] [Related]
15. A prospective study of screening for hypertensive disorders of pregnancy at 11-13 weeks in a Scandinavian population.
Skråstad RB; Hov GG; Blaas HG; Romundstad PR; Salvesen KÅ
Acta Obstet Gynecol Scand; 2014 Dec; 93(12):1238-47. PubMed ID: 25146367
[TBL] [Abstract][Full Text] [Related]
16. Maternal Serum PLGF, PAPPA, β-hCG and AFP Levels in Early Second Trimester as Predictors of Preeclampsia.
Duan H; Zhao G; Xu B; Hu S; Li J
Clin Lab; 2017 May; 63(5):921-925. PubMed ID: 28627818
[TBL] [Abstract][Full Text] [Related]
17. First trimester maternal serum vitamin D and markers of preeclampsia.
Bomba-Opon DA; Brawura-Biskupski-Samaha R; Kozlowski S; Kosinski P; Bartoszewicz Z; Bednarczuk T; Wielgos M
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1078-9. PubMed ID: 24050181
[TBL] [Abstract][Full Text] [Related]
18. Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention.
Moore GS; Allshouse AA; Winn VD; Galan HL; Heyborne KD
Pregnancy Hypertens; 2015 Oct; 5(4):280-6. PubMed ID: 26597741
[TBL] [Abstract][Full Text] [Related]
19. Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia.
Luewan S; Teja-Intr M; Sirichotiyakul S; Tongsong T
Singapore Med J; 2018 Jan; 59(1):55-59. PubMed ID: 28451695
[TBL] [Abstract][Full Text] [Related]
20. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
Yu N; Cui H; Chen X; Chang Y
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
